J Puig-Barbera
Overview
Explore the profile of J Puig-Barbera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borralleras C, Eiros J, Castrodeza Sanz J, Arrazola P, Camara Hijon C, Fernandez-Prada M, et al.
Rev Esp Quimioter
. 2023 Sep;
36(6):658-660.
PMID: 37675837
No abstract available.
2.
Borralleras C, Eiros J, Castrodeza Sanz J, Arrazola P, Camara Hijon C, Fernandez-Prada M, et al.
Rev Esp Quimioter
. 2023 Jun;
36(5):507-515.
PMID: 37303137
Objective: Vaccination against SARS-CoV-2 is essential to mitigate the personal, social and global impact of the coronavirus disease (COVID-19) as we move from a pandemic to an endemic phase. Vaccines...
3.
Arrazola Martinez M, Eiros Bouza J, Plans Rubio P, Puig-Barbera J, Ruiz Aragon J, Torres Lana A
Rev Esp Quimioter
. 2023 Apr;
36(4):334-345.
PMID: 37079707
Most of the complications and deaths related to seasonal flu occur in the elderly population (≥65 years) with comorbidities, and the influenza vaccine is the most effective way to prevent...
4.
Arnedo-Pena A, Puig-Barbera J, Artero-Civera A, Romeu-Garcia M, Meseguer-Ferrer N, Fenollosa-Amposta C, et al.
Allergol Immunopathol (Madr)
. 2020 May;
48(6):694-700.
PMID: 32402624
Introduction: There are few atopic dermatitis (AD) incidence cohort studies in young adults, the etiology of this disease remains obscure, and AD risk factors in adults are not well understood....
5.
Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador F, Librero-Lopez J, Diez-Domingo J, et al.
Vaccine
. 2017 Sep;
35(43):5799-5807.
PMID: 28941618
Background: Concerns have been raised about intraseasonal waning of the protection conferred by influenza vaccination. Methods: During four influenza seasons, we consecutively recruited individuals aged 18years or older who had...
6.
Munoz-Quiles C, Lopez-Lacort M, Domenech-Clar R, Puig-Barbera J, Diez-Domingo J
Rev Clin Esp (Barc)
. 2016 Aug;
216(9):508-510.
PMID: 27478055
No abstract available.
7.
Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador F, Belenguer-Varea A, Carballido-Fernandez M, et al.
Euro Surveill
. 2015 Mar;
20(8).
PMID: 25742432
Preliminary results for the 2014/15 season indicate low to null effect of vaccination against influenza A(H3N2)-related disease. As of week 5 2015, there have been 1,136 hospital admissions, 210 were...
8.
Navarro-Illana P, Caballero P, Tuells J, Puig-Barbera J, Diez-Domingo J
An Pediatr (Barc)
. 2015 Jan;
83(5):318-27.
PMID: 25619797
Introduction: In October 2008, Valencian Community started its human papillomavirus (HPV) vaccination schedules for 14 year-old girls. The aim of this study is to assess knowledge about HPV infection and...
9.
Rondy M, Launay O, Puig-Barbera J, Gefenaite G, Castilla J, De Gaetano Donati K, et al.
Euro Surveill
. 2015 Jan;
20(2).
PMID: 25613779
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target population is sparse. We conducted...
10.
Puig-Barbera J, Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo J, Pastor-Villalba E, Martinez-Ubeda S, et al.
Vaccine
. 2014 Aug;
32(42):5447-54.
PMID: 25131737
Background: The use of intradermal vaccination or virosomal vaccines could increase protection against influenza among the vulnerable population of older adults. Studies assessing the comparative effectiveness of these two influenza...